Charles E. Protzman - Concepedia

Author

Charles E. Protzman

Allergan (United States)

Also Known As

C E Protzman, C. E. PROTZMAN, C. E. Protzman, C.E. Protzman, CHARLES E. PROTZMAN, Charles E. Protzman

Publications

829

Citations

H-Index

Concepts

All Affiliations

Allergan (United States)Allergan (Ireland)

About

Charles E. Protzman is an author at Allergan (United States) specializing in medicine, pharmacology, and ophthalmology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	299
2	Natural Sciences	2	2	64
3	Allergy	2	2	71
4	Biochemistry	2	2	64
5	Cell Biology	1	1	38

Charles E. Protzman

Publications

822

Citations

H-Index

Page 1

	Year	Citations
Pharmacological Characterization of a Novel Antiglaucoma Agent, Bimatoprost (AGN 192024) David F. Woodward, Achim H.‐P. Krauss, J. Chen, Journal of Pharmacology and Experimental Therapeutics	2003	146
Prostaglandin Ethanolamides (Prostamides): In Vitro Pharmacology and Metabolism Isabel Matias, J. Chen, Luciano De Petrocellis, Journal of Pharmacology and Experimental Therapeutics	2004	132
Studies on the ocular pharmacology of prostaglandin D2. David F. Woodward, S B Hawley, Linda S. Williams, PubMed InflammationOcular DiseaseSignal TransductionOphthalmologyIntraocular Pressure	1990	86
Comparison of Prostaglandin F2α, Bimatoprost (Prostamide), and Butaprost (EP2 Agonist) on Cyr61 and Connective Tissue Growth Factor Gene Expression Yanbin Liang, Chen Li, V.M. Guzman, Journal of Biological Chemistry	2003	74
Identification of an antagonist that selectively blocks the activity of prostamides (prostaglandin‐ethanolamides) in the feline iris David F. Woodward, Achim H.‐P. Krauss, J W Wang, British Journal of Pharmacology	2006	61
Bimatoprost and prostaglandin F2α selectively stimulate intracellular calcium signaling in different cat iris sphincter cells Clayton S. Spada, Achim H.‐P. Krauss, David F. Woodward, Experimental Eye Research Molecular PhysiologySignal TransductionOphthalmologyCell SignalingPhysiology	2004	42
Replacement of the carboxylic acid group of prostaglandin F<sub>2α</sub> with a hydroxyl or methoxy substituent provides biologically unique compounds David F. Woodward, Achim H.‐P. Krauss, J. Chen, British Journal of Pharmacology Bioorganic ChemistrySecondary MetaboliteUnique CompoundsExperimental PharmacologyCellular Physiology	2000	38
Prostanoid-induced blood-aqueous barrier breakdown in rabbits involves the EP2 receptor subtype. Charles E. Protzman, David F. Woodward PubMed ImmunologyPharmacotherapyExperimental PharmacologyInflammationMolecular Pharmacology	1990	36
Further studies on ocular responses to DP receptor stimulation David F. Woodward, Clayton S. Spada, S B Hawley, European Journal of Pharmacology Dp Receptor StimulationRetinaOphthalmologyExperimental OphthalmologyNeuroscience	1993	36
Identification of 19 (R)-OH prostaglandin E2 as a selective prostanoid EP2-receptor agonist D.F. Woodward, Charles E. Protzman, Achim H.‐P. Krauss, Prostaglandins Prostaglandin E2AllergyG Protein-coupled ReceptorMedicineMechanism Of Action	1993	35

Page 1